You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

RETRACTION article

Front. Cell Dev. Biol., 15 September 2023

Sec. Signaling

Volume 11 - 2023 | https://doi.org/10.3389/fcell.2023.1260259

Retraction: GATA4 regulates inflammation-driven pancreatic ductal adenocarcinoma progression

Article metrics

View details

8,4k

Views

3,4k

Downloads

Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies.

As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted.

The co-authors, Dr. Weiliang Jiang and Dr. Jie Shen agreed to this retraction.

This retraction was approved by the Chief Editor of Frontiers in Cellular and Developmental Biology and the Editor-in-Chief of Frontiers.

Summary

Keywords

GATA4, Pancreatic Ductal Adenocarcinoma, inflammatio, LPS, tumor-associated macrophage

Citation

Frontiers Editorial Office (2023) Retraction: GATA4 regulates inflammation-driven pancreatic ductal adenocarcinoma progression. Front. Cell Dev. Biol. 11:1260259. doi: 10.3389/fcell.2023.1260259

Received

17 July 2023

Accepted

15 August 2023

Published

15 September 2023

Approved by

Ana Cuenda, Spanish National Research Council (CSIC), Spain

Volume

11 - 2023

Updates

Copyright

*Correspondence: Frontiers Editorial Office,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics